Global Market" has been added to ResearchAndMarkets.com's offering.The global fusion proteins market is poised to expand ...

A promising breakthrough in autoimmune disease research may open the door to safer and more effective treatments. Scientists ...

Hello, and welcome to the Deutsche Bank Virtual Investor Conference, dbVIC. This is Zafar Aziz from the Deutsche Bank team. I'm pleased to welcome our next presentation from Belite Bio, whose ADRs are ...

MK-677 (also known as ibutamoren or MK-0677) is an orally active ghrelin receptor (GHSR-1a) agonist that increases pul ...

In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel ...

TX45 improved both left heart function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with reduced ...

In Q1 FY26, cash receipts from customers were A$15k. The net cash used in G&A activities in the quarter was A$578k, compared to A$1.44 million in Q4 FY25. Payments to Related Parties comprises ...

Florida Supplement Company Publishes Educational Resource Examining Green Tea, Berberine, Apple Cider Vinegar, Chromium, Cinnamon, and Ginger Formulations-Compares DIY Recipes to Measured-Dose Capsule ...

Q3 2025 Earnings Call Transcript October 29, 2025 OPKO Health, Inc. beats earnings expectations. Reported EPS is $0.03, ...

Good morning, and welcome to the SELLAS Life Sciences R&D Day. As a reminder, this call is being recorded, and a replay will be made available on the SELLAS website following the conclusion of the ...